Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > NEWSTRIKE 19 Million CANNIMED CEO CRAZY
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Mdaw94on Dec 24, 2017 11:34am
147 Views
Post# 27223848

RE:RE:RE:RE:RE:NEWSTRIKE 19 Million CANNIMED CEO CRAZY

RE:RE:RE:RE:RE:NEWSTRIKE 19 Million CANNIMED CEO CRAZYLol sorry maybe that was a bit harsh. Nothing personal just a little late night hockey trash talk. So it's not that your necessarily against the offer, just hoping they up it a bit? I remember reading back in June when Cmed stock was down you guys were hoping Cmed would take 15 from Canopy. Auroras premium is higher. Personally I think it would be a great fit. Wish it went friendly though. Times wasting. Cmed is a good company with a strong product line. Acb would expedite that success 10 fold imo
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities